Adebrelimab and Chemoradiotherapy in High-risk LANPC
Adebrelimab and Chemoradiotherapy in High-risk LANPC
Recruiting · NCT06349889 · Registry updated 2025-01-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Adebrelimab and Chemoradiotherapy in High-risk LANPC | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, malignant tumor of nasopharynx, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease | Recruiting | Phase 2 | 2025-01-15 | NCT06349889 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Nanfang Hospital, Southern Medical University | 248 |
| Sun Yat-sen University | 606 |
| The First Affiliated Hospital of Xiamen University | 107 |
| West China Hospital | 359 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Nanfang Hospital, Southern Medical University | Guangzhou | China | 4 |
| Sun Yat-sen University Cancer Center | Guangzhou | China | 61 |
| The First Affiliated hospital of Xiamen University | Xiamen | China | 69 |
| West China Hospital, Sichuan University | Chengdu | China | 14 |